Navigating SCAN Health Plan Genetic Testing Prior Authorization

Klivira ResearchKlivira Research9 min read

Successfully managing SCAN Health Plan genetic testing prior authorization requires precise documentation and adherence to payer-specific criteria. This guide details the operational steps for effective submission and adjudication.

Managing prior authorization (PA) for genetic testing presents specific operational challenges for healthcare organizations. When dealing with SCAN Health Plan genetic testing prior authorization, these complexities are compounded by payer-specific policies and the evolving landscape of genetic diagnostics. Revenue cycle and prior authorization teams must navigate intricate clinical criteria, precise documentation requirements, and varied submission pathways to ensure timely approvals. This guide provides an operator-to-operator overview of the process, focusing on actionable steps for efficient adjudication.

Understanding SCAN Health Plan's Genetic Testing PA Framework

SCAN Health Plan, like other payers, establishes specific medical policies for genetic testing based on clinical evidence and established guidelines. These policies delineate which tests require prior authorization and under what clinical circumstances they are considered medically necessary. Operational teams must access and interpret SCAN's current genetic testing medical policies, typically available on their provider portal or through direct inquiry. Adherence to these payer-specific criteria is fundamental for successful PA submission.

Essential Documentation for Genetic Testing PA

  • **Clinical Notes:** Detailed physician notes supporting the medical necessity of the genetic test, including patient history, physical examination findings, and previous diagnostic workups.
  • **Genetic Counseling Records:** Documentation of pre- and post-test genetic counseling, if performed, outlining the rationale for testing and patient understanding.
  • **Relevant Lab Results:** Any prior lab results that inform the decision for genetic testing, such as tumor markers, metabolic panels, or preliminary genetic screens.
  • **Family History:** A comprehensive family pedigree detailing relevant genetic conditions, particularly for inherited disorders.
  • **ICD-10 Codes:** Accurate and specific diagnostic codes reflecting the patient's condition that necessitates genetic testing.
  • **CPT Codes:** Correct procedural codes for the specific genetic test(s) being requested.
  • **Letter of Medical Necessity:** A concise letter from the ordering provider summarizing the clinical rationale and how the test results will impact patient management.

Clinical Criteria and Justification

SCAN Health Plan often references established clinical criteria sets, such as those from MCG Health or InterQual, to evaluate the medical necessity of genetic testing requests. These criteria provide objective guidelines for specific conditions and genetic panels. Prior authorization coordinators must ensure that the submitted clinical documentation clearly aligns with the applicable criteria points. Proactively mapping patient data to these criteria before submission can significantly reduce denial rates and accelerate the approval process.

Submission Pathways: X12 278 and Payer Portals

Providers typically submit SCAN Health Plan genetic testing prior authorization requests via electronic or manual channels. The HIPAA-mandated X12 278 transaction is the preferred electronic method, enabling direct system-to-system communication between providers and payers. Many organizations also utilize payer-specific web portals, such as Availity or the SCAN provider portal, which offer a structured interface for submitting requests and attaching supporting documentation. Third-party ePA solutions, like CoverMyMeds, can also facilitate submissions across multiple payers and integrate with EHR systems.

The Prior Authorization Adjudication Process

Upon receipt, SCAN Health Plan's medical review team assesses the submitted PA request against their medical policies and clinical criteria. This process involves a thorough review of all provided documentation to confirm medical necessity and appropriateness of the genetic test. The Da Vinci PAS (Prior Authorization Support) implementation guide, based on FHIR, aims to standardize and accelerate this exchange of information. Timely and complete submission of information minimizes delays during this adjudication phase.

Addressing Denials and Peer-to-Peer Review

Should a SCAN Health Plan genetic testing prior authorization request be denied, the operational team must initiate the appeals process promptly. This often involves submitting additional clinical documentation, clarifying aspects of the initial request, or engaging in a peer-to-peer (P2P) discussion. During a P2P review, the ordering provider directly discusses the clinical rationale with a SCAN medical director, often leading to reconsideration and approval when medical necessity is clearly articulated. Thorough preparation for P2P discussions, including a concise summary of the case and criteria alignment, is critical.

Integrating Technology for Prior Authorization Efficiency

Modernizing the prior authorization workflow through technology can significantly improve efficiency for genetic testing requests. EHR systems like Epic Hyperspace or Cerner PowerChart can integrate with ePA platforms via SMART on FHIR, automating data extraction and submission. This reduces manual data entry, minimizes errors, and provides real-time status updates on PA requests. Implementing such solutions helps operational teams manage the volume and complexity of SCAN Health Plan genetic testing prior authorization with greater accuracy and speed.

Frequently asked questions

What is the typical turnaround time for SCAN Health Plan genetic testing prior authorization?

Turnaround times vary based on the completeness of the submission and the complexity of the genetic test requested. While electronic submissions via X12 278 can accelerate initial processing, comprehensive clinical review may still take several business days. Expedited review processes are typically reserved for urgent clinical situations, requiring specific documentation of medical urgency.

Can I submit a PA for multiple genetic tests on a single form to SCAN Health Plan?

Payer policies on combined submissions vary. It is best practice to consult SCAN Health Plan's specific guidelines or their provider manual. Often, if multiple tests are clinically interdependent and requested for the same patient encounter and diagnosis, they may be submitted together with clear justification for each. However, separate requests might be required for distinct clinical questions or unrelated tests.

What if SCAN Health Plan requests additional information for a genetic testing PA?

If SCAN Health Plan requests additional information (RFI), operational teams must provide the requested documentation promptly. Delays in responding to RFIs can lead to denials or prolonged adjudication times. Ensure the submitted information directly addresses the payer's specific questions and is clearly linked to the original PA request to avoid further back-and-forth.

Are there specific CPT codes for genetic counseling that require prior authorization with SCAN Health Plan?

While genetic testing CPT codes often require PA, codes for genetic counseling (e.g., 96040) generally do not, as they are considered evaluation and management services. However, it is always prudent to verify the most current SCAN Health Plan medical policies for any specific requirements related to counseling services, as policies can change.

How do I determine if a genetic test is considered 'experimental' or 'investigational' by SCAN Health Plan?

SCAN Health Plan's medical policies explicitly state which genetic tests they consider experimental or investigational, making them non-covered services. These policies are based on the latest clinical evidence and regulatory approvals. Providers must review these policies carefully before ordering tests to avoid denials based on coverage limitations. If a test is deemed investigational, an appeal based on unique patient circumstances with robust clinical evidence might be considered.

Related coverage

Klivira automates prior authorization end-to-end.

See how it works for your EMR, payer mix, and specialty.

Or email hello@klivira.com.